| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI112270 |
| P8608 | Fatcat ID | release_fovcx3bjf5bvpizriywbd6fqyu |
| P932 | PMC publication ID | 423321 |
| P698 | PubMed publication ID | 2935559 |
| P2093 | author name string | Mancini M | |
| Mattioli PL | |||
| Spina M | |||
| Manzo C | |||
| Cerbone AM | |||
| Coraggio F | |||
| Capitanio AM | |||
| Scarpato P | |||
| DiMinno G | |||
| Dattoli GM | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes | Q33339989 | ||
| An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia | Q33463846 | ||
| Exposure of platelet fibrinogen receptors by ADP and epinephrine | Q33473239 | ||
| Cycles of Agglutination-Disagglutination Induced by Ristocetin in Thrombasthenic Platelets | Q33473264 | ||
| Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP | Q33476492 | ||
| Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias | Q33476621 | ||
| Molecular defects in interactions of platelets with the vessel wall | Q33477754 | ||
| Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II. | Q33478516 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa | Q33821916 | ||
| Functionally thrombasthenic state in normal platelets following the administration of ticlopidine | Q34528200 | ||
| A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells | Q34536168 | ||
| Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets | Q36314768 | ||
| New Data on Glanzmann's Thrombasthenia | Q36562989 | ||
| Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen | Q37007168 | ||
| Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder | Q37021334 | ||
| Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody | Q37026661 | ||
| Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant | Q37027827 | ||
| Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody | Q37609861 | ||
| pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-Sepharose | Q39293270 | ||
| Biological properties of myeloma proteins | Q39313697 | ||
| Hemostatic abnormalities associated with dysproteinemias | Q39925474 | ||
| Platelets and their membranes in hemostasis: physiology and pathophysiology | Q40296235 | ||
| Abnormal fibrin ultrastructure, polymerization, and clot retraction in multiple myeloma | Q43775158 | ||
| Inflammation and Haemostasis in Paraproteinaemias | Q47761093 | ||
| Bleeding syndrome in a patient with IgA myeloma: interaction of protein and connective tissue. | Q53728881 | ||
| Antibody activity of human myeloma globulins. | Q54017661 | ||
| Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin | Q66955875 | ||
| Inhibition of fibrin monomer polymerization by lambda myeloma globulins | Q67276695 | ||
| Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function | Q67325000 | ||
| Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis | Q67556563 | ||
| Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex | Q68934463 | ||
| The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis | Q70549345 | ||
| Correlation between fibrinogen binding to human platelets and platelet aggregability | Q71496685 | ||
| Dissociation of the glycoprotein IIb-IIIa complex in isolated human platelet membranes. Dependence of pH divalent cations | Q72761668 | ||
| Purification of glycoproteins IIb and III from human platelet plasma membranes and characterization of a calcium-dependent glycoprotein IIb-III complex | Q72762726 | ||
| Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex | Q72771425 | ||
| Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies | Q72779664 | ||
| Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets | Q72797414 | ||
| Circulating Heparan Sulfate Anticoagulant in a Patient with a Fatal Bleeding Disorder | Q72815927 | ||
| Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets | Q72895038 | ||
| Hemostatic defects in dysproteinemias | Q93801429 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| blood coagulation disease | Q890200 | ||
| P304 | page(s) | 157-164 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder | |
| P478 | volume | 77 |
| Q43656350 | A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange |
| Q46804451 | A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry |
| Q33902343 | Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism |
| Q33502377 | Acquired Glanzmann's thrombasthenia associated with Hodgkin's lymphoma: a case report and review of the literature |
| Q69534854 | Acquired disorders of platelet function |
| Q40919205 | Binding of fibrinogen to human monocytes |
| Q91979072 | Bleeding Disorders Associated with Cancer |
| Q41033283 | Coagulation disorders in cancer |
| Q68446439 | Effect of GPIIb-IIIa complex ligands on calciumion movement and cytoskeleton organization in activated platelets |
| Q36475853 | Gastrointestinal bleeding as an initial manifestation in asymptomatic multiple myeloma: A case report and review of the literature |
| Q64111233 | Gastrointestinal bleeding as initial presentation of extramedullary plasma cell neoplasms: A case report and review of the literature |
| Q69534846 | Glanzmann's thrombasthenia |
| Q37868637 | Guidelines for supportive care in multiple myeloma 2011. |
| Q39127942 | Hemostatic defects in cancer patients |
| Q47727328 | Identifying human platelet glycoproteins IIb and IIIa by capillary electrophoresis |
| Q33830358 | IgMk paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report |
| Q33428926 | Immunology of platelet disorders |
| Q33328304 | Inhibitory and activating human antiplatelet antibodies |
| Q41403458 | Interrelation of platelet aggregation, release reaction and thromboxane A2 production |
| Q43240271 | Massive intra-abdominal bleeding complicating bone marrow aspiration and biopsy in multiple myeloma |
| Q39521330 | Plasma cell dyscrasias: current status |
| Q50459104 | Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery. |
| Q34530416 | Rare acquired bleeding disorders |
| Q47961621 | Rare complication of treated immune thrombocytopenia. |
| Q41553346 | The biologic and clinical spectrum of Glanzmann's thrombasthenia: implications of integrin alpha IIb beta 3 for its pathogenesis |
| Q87044766 | The effect of paraprotein on platelet aggregation |
| Q33444982 | The immunogenicity of platelet membrane glycoproteins |
| Q37783022 | The monoclonal gammopathies (paraproteins). |
Search more.